Related Experiment Video
Updated: Sep 30, 2025
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
553
The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?
Zahra Ilyas1,2, Simone Perna2, Tariq A Alalwan2
1Department of Laboratory, Bahrain Specialist Hospital, Juffair P.O. Box 10588, Bahrain.
Nutrients
|March 12, 2022
Summary
The ketogenic diet (KD) shows promise in managing sarcopenic obesity by improving metabolic health, reducing visceral fat, and enhancing body composition. Further research is needed to confirm long-term effects and establish general recommendations.
Area of Science:
- Metabolic Health
- Nutritional Science
- Obesity Research
Background:
- Sarcopenic obesity presents significant metabolic challenges.
- Combined sarcopenia and obesity lead to adverse health outcomes.
- Effective management strategies are crucial for this patient population.
Purpose of the Study:
- To evaluate the effectiveness of the ketogenic diet (KD) for sarcopenic obesity.
- To explore KD's potential to reduce visceral adipose tissue (VAT) and liver fat.
- To assess KD's impact on gut microbiota, inflammation, and body composition.
Main Methods:
- This study is a narrative review.
- It synthesizes existing research on ketogenic diets and sarcopenic obesity.
- Focuses on metabolic and body composition changes.
Main Results:
- Ketogenic diet improves metabolic health and glycaemia control in obesity.
- KD positively impacts VAT, adipose tissue, and cytokines.
- Evidence suggests benefits for gut microbiota and body composition.
Conclusions:
- Ketogenic diet is a potential therapeutic option for sarcopenic obesity.
- KD demonstrates positive effects on key health markers.
- Long-term KD effects require further investigation before widespread recommendations.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
95
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
95
01:15Hypoglycemia and Glucagon
363
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
363
01:24Obesity
662
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
662
01:15Diabetes: Management and Pharmacotherapy
427
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
427
01:24Metabolic States of the Body: Fasting and Starvation
1.9K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
1.9K
01:21Overview of Protein Metabolism
2.1K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
2.1K